Hypoxia Inducible Factor as a Cancer Drug Target

Current Cancer Drug Targets

Volumn 3, Issue 6, 2003, Pages 391-405

  Welsh, Sarah J ^a   Powis, Garth ^a  

^a UNIVERSITY OF ARIZONA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

1 BENZYL 3 (5 HYDROXYMETHYL 2 FURYL)INDAZOLE; 2 AMINO 3 [4 N,N BIS(2 CHLOROETHYL)AMINO]PHENYLPROPIONIC ACID N OXIDE; 2 METHOXYESTRADIOL; ANTINEOPLASTIC AGENT; CAMPTOTHECIN DERIVATIVE; GELDANAMYCIN; HYPOXIA INDUCIBLE FACTOR 1; HYPOXIA INDUCIBLE FACTOR 1ALPHA; OXYGEN; PACLITAXEL; PROPIONIC ACID DERIVATIVE; PX 478; UNCLASSIFIED DRUG; VINCRISTINE;

ALPHA CHAIN; ANGIOGENESIS; APOPTOSIS; BETA CHAIN; CANCER CHEMOTHERAPY; CELL NUCLEUS; DRUG TARGETING; GENE ACTIVATION; GENE OVEREXPRESSION; GENETIC TRANSCRIPTION; GLYCOLYSIS; HYPOXIA; METASTASIS INHIBITION; PROGNOSIS; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN TRANSPORT; REVIEW; SOLID TUMOR; TREATMENT FAILURE;

ANIMALS; ANTINEOPLASTIC AGENTS; CELL HYPOXIA; DNA-BINDING PROTEINS; HUMANS; HYPOXIA-INDUCIBLE FACTOR 1; HYPOXIA-INDUCIBLE FACTOR 1, ALPHA SUBUNIT; NEOPLASMS; NUCLEAR PROTEINS; OXYGEN; SIGNAL TRANSDUCTION; TRANSCRIPTION FACTORS;

EID: 0347512126     PISSN: 15680096     EISSN: None     Source Type: Journal    
DOI: 10.2174/1568009033481732     Document Type: Review

References (211)

1. Hoeckel, M.; Schlenger, K.; Hoeckel, S.; Vaupel, P. Hypoxic Cervical Cancers With Low Apoptotic Index Are Highly Aggressive. Cancer Res. 2001, 59, 4525-4528.
2. Birner, P.; Gatterbauer, B.; Oberhuber, H, Schindl, M.; Rossler, K.; Prodinger, A.; Budka, H.; Hainfellner, J. A. Expression of Hypoxia-Inducible Factor-1 Alpha in Oligodendrogliomas: Its Impact on Prognosis and on Neoangiogenesis. Cancer 2001, 92, 165-171.
3. Bos, R.; Zhong, H.; Hanrahan, C. F.; Mommers, E. C.; Semenza, G. L.; Pinedo, H. M.; Abelof, F. M. D.; Simons, J. W.; Van Diest, P. J.; Van Der Wall, E. Levels of Hypoxia-Inducible Factor-1 Alpha During Breast Carcinogenesis. J. Natl. Cancer Inst. 2001, 93, 309-314.
4. Bos, R.; Van Der Groep, P.; Greijer, A. E.; Shvarts, A.; Meijer, S.; Pinedo, H. M.; Semenza, G. L.; Van Diest, P. J.; Van Der Wall, E. Levels of Hypoxia-Inducible Factor-1alpha Independently Predict Prognosis in Patients With Lymph Node Negative Breast Carcinoma. Cancer 2003, 97, 1573-1581.
5. Gray, L. H.; Conger, A. D.; Ebert, M.; Hornsey, S.; Scott, O. C. Concentration of Oxygen Dissolved in Tissues at the Time of Irradiation as a Factor in Radiotherapy. Br. J. Radiol. 1953, 26, 638-648.
6. Moulder, J. D.; Rockwell, S. Tumor Hypoxia: Its Impact on Cancer Therapy. Cancer Metast. Rev. 1987, 5, 313-341.
7. Nordsmark, M.; Hoyer, M.; Keller, J.; Nielson, O. S.; Jensen, O. M.; Overgaard, J. The Relationship Between Tumor Oxygenation and Cell Proliferartion in Human Soft Tissue Sarcomas. Int. J. Radiat. Oncol. Biol. Phys. 1996, 35, 701-708.
8. Thomlinson, R.; Gray, L. The Histological Structure of Some Human Lung Cancers and the Possible Implications For Radiotherapy. Br. J. Cancer 1955, 9, 539-549.
9. Brown, J. M.; Giaccia, A. J. The Unique Physiology of Solid Tumors: Opportunities and (Problems) for Cancer Therapy. Cancer Res. 1998, 58, 1408-1416.
10. Hoeckel, M.; Schlenger, K.; Aral, B.; Mitza, M.; Schaffer, U.; Vaupel, P. Association Between Tumour Hypoxia and Malignant Progression in Advanced Cancer of the Uterine Cervix. Cancer Res. 1996, 56, 4509-4515.
11. Semenza, G. L. HIF-1 and Tumor Progession: Pathophysiology and Therapeutics. Trends Mol. Med. 2002, 8, S62-S67.
12. Wildiers, H.; Guetens, G.; De Boeck, G.; Landuyt, W.; Verbeken, E.; Highley, M.; De Bruijn, E. A.; Van Oosterom, A. Melphalan Availability in Hypoxia-Inducible Factor-1alpha +/+ and Factor-1alpha-/Tumors is Independent of Tumor Vessel Density and Correlates With Melphalan Erythrocyte Transport. Int. J. Cancer 2002, 99, 514-519.
13. Semenza, G. L. Hypoxia, Clonal Selection, and the Role of HIF-11 in Tumor Progression. Crit. Rev. Biochem. Mol. Biol. 2000, 35, 71-103.
14. Brizel, D. M.; Sibley, G. S.; Prosnitz, L. R.; Scher, R. L.; Dewhirst, M. W. Tumor Hypoxia Adversely Affects the Prognosis of Carcinoma of the Head and Neck. Int. J. Radiat. Oncol. Biol. Phys. 1997, 38, 285-289.
15. Hanahan, D.; Folkman, J. Patterns and Emerging Mechanisms of the Angiogenic Switch During Tumorigenesis. Cell 1996, 86, 353-364.
16. Ryan, H. E.; Lo, J.; Johnson, R. S. HIF-1 Alpha is Required For Solid Tumor Formation and Embryonic Vascularization. EMBO J. 1998, 17, 3005-3015.
17. Dachs, G. U.; Tozer, G. M. Hypoxia Modulated Gene Expression: Angiogenesis, Metastasis and Therapeutic Exploitation. Eur. J. Cancer 2000, 36, 1649-1660.
18. Saunders, M.; Dische, S. Clinical Results of Hypoxic Cell Radiosensitisation From Hyperbaric Oxygen to Accelerated Radiotherapy, Carbogen and Nicotinamide. Brit. J. Cancer 1996, 27, S271-S278.
19. Overgaard, J.; Horsman, M. R. Modification of Hypoxia-Induced Radioresistance in Tumors by the Use of Oxygen and Sensitzers. Sem. Radiat. Oncol. 1996, 6, 10-21.
20. Haffty, B. G.; Son, Y. H.; Papac, R.; Sasaki, C. T.; Weissberg, J. B.; Fischer, D.; Rockwell, S. S.; Sartorelli, A. C.; Fisher, J. J. Chemotherapy as an Adjunct to Radiation in the Treatment of Squamous Cell Carcinoma of the Head and Neck: Results of the Yale Mitomycin Randomized Trials. J. Clinical. Oncol. 1997, 15, 268-276.
21. Sartorelli, A. C. Therapeutic Attack of Hypoxic Cells of Solid Tumors. Cancer Res. 1988, 48, 775-778.
22. Oosteen, E. A.; Speckamp, W. N. Mitomycin C Analogues 1. Indoloquinones as Potential Bisalkylating Agents. Tetrahedron 1987, 43, 255-267.
23. Boland, M. P.; Knox, R. J.; Roberts, J. J. The Differences in Kinetics of Rat and Human DT Diaphorase Result in a Differential Sensitivity of Derived Cell Lines to CB 1954 (5-(Aziridin-1-Y1)-2,4-Dinitrobenzamide). Biochem. Pharmacol. 1991, 41, 867-875.
24. Naylor, M. A.; Thomson, P. Recent Advances in Bioreductive Drug Targeting. Mini Rev. Med Chem. 2001, 1, 17-29.
25. Brown, J. M.; Siim, B. G. Hypoxia-Specific Cytotoxins in Cancer Therapy. Semin. Radial Oncol. 1996, 6, 22-36.
26. Stani, S. C.; Capaccetti, B.; Bonginelli, P.; Sarmiento, R.; De Sio, L.; Fanelli, M; Gasparini, G. Antiangiogenic Agents. Suppl. Tumori 2002, 1, S39-S43.
27. Via, L, E.; Gore-Langton, R. E.; Pluda, J. M. Clinical Trials Referral Resource. Current Clinical Trials Administering the Antiangiogenesis Agent. Oncology 2000, 14, 1312-1323.
28. Moore, J. M.; Patapoff, T. W.; Cromwell, M. E. Kinetics and Thermodynamics of Dimer Formation and Dissociation for a Recombinant Humanized Monoclonal Antibody to Vascular Endothelial Growth Factor. Biochemistry 1999, 38, 13960-13967.
29. Kerbel, RS.; Yu, J.; Tran, J.; Man, S.; Viloria-Petit, A.; Klement, G.; Coomber, BL.; Rak, J. Possible Mechanisms of Acquired Resistance to Anti-Angiogenic Drugs: Implications For the Use of Combination Therapy Approaches. Cancer Metast. Rev. 2001, 20, 79-86.
30. Kerbel, R. S. Clinical Trials of Antiangiogenic Drugs: Opportunities, Problems, and Assessment of Initial Results. J. Clin. Oncol. 2001, 19, 45S-518.
31. Semenza, G. L. Hypoxia-Inducible Factor 1: Oxygen Homeostasis and Disease Pathophysiology. Trends Mol. Med. 2001, 7, 345-350.
32. Seagroves, T. N.; Ryan, H. E.; Lu, H.; Wouters, B. G.; Knapp, M.; Thibault, P.; Laderoute, K.; Johnson, R. S. Transription Factor HIF-1 is a Necessary Mediator of the Pasteur Effect in Mammalian Cells. Mol. Cell Biol. 2001, 21, 3436-3444.
33. Ravi, R.; Mookerjee, B.; Bhujwalla, Z. M.; Sutter, C. H.; Artemov, D.; Zeng, Q.; Dillehay, L. E.; Madan, A.; Semenza, G. L.; Bedi, A. Regulation of Tumor Angiogenesis by P53-Induced Degradation of Hypoxia-Inducible Factor 1 Alpha. Genes Dev. 2000, 14, 34-44.
34. Kung, A. L.; Wang, S.; Klco, J. M.; Kaein, W. G. Suppression of Tumor Growth Through Disruption of Hypoxia-Inducible Transcription. Nature Med. 2000, 8, 1335-1340.
35. Michel, G.; Minet, E.; Ernest, I.; Roland, I.; Durant, F.; Remacle, J.; Michiels, C. A Model for the Complex between the Hypoxia-Inducible Factor-1(HIF-1) and Its Consensus DNA Sequence. J. Biomol. Struct. Dyn. 2000, 18, 169-179.
36. Crews, S. T.; Fan, C. M. Remembrance of Things Pass: Regulation of Development by Bhlh-PAS Proteins. Curr. Opin. Genet. Dev. 1999, 9, 580-587.
37. Talks, K. L.; Turley, H.; Gatter, K. C.; Maxwell, P. H.; Pugh, C. W.; Ratcliffe, P. J.; Harris, A. L. the Expression and Distribution of the Hypoxia-Inducible Factors HIF-1alpha and HIF-2alpha in Normal Human Tissues, Cancers, and Tumor-Associated Macrophages. Am. J. Pathol. 2000, 157, 411-421.
38. Yu, A.Y.; Shimoda, L. A.; Iyer, N. V.; Huso, D. L.; Sun, X.; Mcwilliams, R.; Beaty, T.; Sham, J. S.; Wiener, C. M.; Sylvester, J. T.; Semenza, G. L. Impaired Physiological Responses to Chronic Hypoxia in Mice Partially Deficient For Hypoxia-Inducible Factor 1 Alpha. J. Clin. Invest. 1999, 103, 691-696.
39. Carmeliet, P.; Dor, Y.; Herbert, J. M.; Fukumura, D.; Brusselmans, K.; Dewerchin, M.; Neeman, M.; Bono, F.; Abramovitch, R.; Maxwell, P.; Koch, C. J.; Ratcliffe, P.; Moons, L.; Jain, R. K.; Colen, D.; Keshert, E.; Keshet, E. Role of HIF-1alpha in Hypoxia-Mediated Apoptosis, Cell Proliferation and Tumour Angiogenesis. Nature 1998, 394, 485-490.
40. Beasley, N. J. P.; Leek, R.; Alam, M.; Turley, H.; Cox, G. J.; Gatter, K.; Millard, P.; Fuggle, S.; Haris, A. L. Hypoxia-Inducible Factors HIF-1α and HIF-2α in Head and Neck Cancer: Relationship to Tumor Biology and Treatment Outcome in Surgically Resected Patients. Cancer Res. 2002, 62, 2493-2497.
41. Maxwell, P. H.; Dachs, G. U.; Gleadle, J. M.; Nicholls, L. G.; Harris, A. L.; Stratford, I. J.; Hankinson, O.; Pugh, C. W.; Ratcliffe, P. J. Hypoxia-Inducible Factor-1 Modulates Gene Expression in Solid Tumors and Influences Both Angiogenesis and Tumor Growth. Proc. Natl. Acad Sci. U.S.A. 1997, 94, 8104-8109.
42. 2 Homeostasis by Hypoxia-Inducible Factor 1 Alpha. Genes Dev. 1998, 12, 149-162.
43. Tian, H.; Hammer, R. E.; Matsumoto, A. M.; Russell, D. W.; Mcknight, S. L. The Hypoxia-Responsive Transcription Factor EPAS1 is Essential for Catecholamine Homeostasis and Protection Against Heart Failure During Embryonic Development. Genes Dev. 1998, 12, 3320-3324.
44. Peng, J.; Zhang, L.; Drysdale, L.; Fong, G. H. The Transcription Factor EPAS-1/Hypoxia-Inducible Factor-2α Plays an Important Role in Vascular Remodeling. Proc. Natl. Acad Sci. USA. 2000, 97, 8386-8391.
45. Kozak, K. R.; Abbott, B.; Hanksinson, O. ARNT-Deficient Mice and Placental Differentiation. Dev. Biol. 1997, 191, 297-305.
46. Hara, S.; Hamada, J.; Kobayashi, C.; Kondo, Y.; Imura, N. Expression and Characterization of Hypoxia-Inducible Factor (HIF)-3alpha in Human Kidney: Suppression of HIF-Mediated Gene Expression by HIF-3alpha. Biochem. Biophys. Res. Commun. 2001, 287, 808-813.
47. Gu, Y. Z.; Moran, S. M.; Hogenesch, J. B.; Wfartman, L.; Bradfield, C. A. Molecular Characterization and Chromosomal Localization of a Third Alpha-Class Hypoxia Inducible Factor Subunit, HIF-3 Alpha. Gene Expr. 1999, 7, 205-213.
48. Makino, Y.; Kanopka, A.; Wilson, W. J.; Tankaka, H.; Poellinger, L. Inhibitory PAS Domain Protein (IPAS) is a Hypoxia-Inducible Splicing Variant of the Hypoxia-Inducible Factor-3α Locus. J. Biol. Chem. 2002, 277, 32405-32408.
49. Aiello, L. P.; Northrup, J. M.; Keyt, B. A.; Takagi, H.; Iwamoto, M. A. Hypoxic Regulation of Vascular Endothelial Growth Factor in Retinal Cells. Arch. Ophthalmol. 1995, 113, 1538-1544.
50. Jiang, B. H.; Rue, E.; Wang, G. L.; Roe, R.; Semenza, G. L. Dimerization, DNA Binding, and Transactivation Properties of Hypoxia-Inducible Factor 1. J. Biol. Chem. 1996, 271, 17771-17778.
51. Maxwell, P. H.; Pugh, C. W.; Ratcliffe, P. J. The pVHL-HIF-1 System. A Key Mediator of Oxygen Homeostasis. Adv. Exp. Med. Biol. 2001, 502, 365-376.
52. 2-Dependent Degradation Domain Via the Ubiquitin-Proteasome Pathway. Proc. Natl. Acad. Sci. U.S.A. 1998, 95, 7987-7992.
53. Kallio, P. J.; Wilson, W. J.; O'Brien, S.; Makino, Y.; Poellinger, L. Regulation of the Hypoxia-Inducible Factor-1α by the Ubiquitin-Proteasome Pathway. J. Biol. Chem. 1999, 274, 6519-6525.
54. Salceda, S.; Caro, J. Hypoxia-Inducible Factor 1α. (HIF-1α) Protein is Rapidly Degtraded by the Ubiquitin-Proteasome System under Normoxcic Conditions: Its Stabilization by Hypoxia Depends Upon Redox-Induced Changes. J. Biol. Chem. 1997, 272, 22642-22647.
55. 2, and the 3 PHDs: How Animal Cells Signal Hypoxia to the Nucleus. Cell 2002, 107, 1-3.
56. Epstein, A. C.; Gleadle, J. M.; Mcneill, L. A.; Hewitson, K. S.; O'Rourke, J.; Mole, D. R.; Mukherji, M.; Metzen, E.; Wilson, M. I.; Dhanda, A.; Tian, Y. M.; Masson, N.; Hamiltion, D. L.; Jaakkola, P.; Barstead, R.; Hodgkin, J.; Maxwell, P. H.; Pugh, C. W.; Schofield, C. J.; Ratcliffe, P. J. C. Elegans EGL-9 and Mammalian Homologs Define a Family of Dioxygenases that Regulate HIF by Prolyl Hydroxylation. Cell 2001, 107, 43-54.
57. Masson, N.; William, C.; Maxwell, P. H.; Pugh, C. W.; Ratcliffe, P. J. Independent Function of Two Destruction Domains in Hypoxia-Inducible Factor-Alpha Chains Activated by Prolyl Hydroxylation. EMBO J. 2001, 20, 5197-5206.
58. An, W. G.; Kanekal, M.; Simon, M.C.; Maltepe, E.; Blagosklonny, M. V.; Neckers, L. M. Stabilization of Wild-Type p53 by Hypoxia-Inducible Factor 1alpha Nature 1998, 392, 405-408.
59. Blagosklonny, M. V.; An, W. G.; Romanova, L. Y.; Trepel, J.; Fojo, T.; Neckers, L. p53 Inhibits Hypoxia-Inducible Factor-Stimulated Transcription. J. Biol. Chem. 1998, 273, 11995-11998.
60. Isaacs, J. S.; Jung, Y. J.; Mimnaugh, E. G.; Martinez, A.; Cuttitta, F.; Neckers, L. M. Hsp90 Regulates a Von Hippel Lindau-Independent Hypoxia-Inducible Factor-1α-Degradative Pathway. J. Biol. Chem. 2002, 277, 29936-29944.
61. Mabjeesh, N. J.; Post, D. E.; Willard, M. T.; Kaur, B.; Van Meir, E. G.; Simons, J. W.; Zhong, H. Geldanamycin Induces Desgradation of Hypoxia-Inducible Factor 1α Protein via the Proteosome Pathway in Prostate Cancer Cells. Cancer Res. 2002, 62, 2478-2482.
62. Gradin, K.; Mcguire, J.; Wenger, R. H.; Kvietikova, I.; Whitelaw, M. L.; Toftgard, R.; Tora, L.; Gassmann, M.; Poellinger, L. Functional Interference between Hypoxia and Dioxin Signal Transduction Pathways: Competition for Recruitment of the ARNT Transcription Factor. Mol. Cell Biol. 1996, 16, 5221-5231.
63. Jiang, B. H.; Jiang, G.; Zheng, J. Z.; Lu, Z.; Hunter, T.; Vogt, P. K. Phosphatidylinositol 3-Kinase Signaling Controls the Levels of Hypoxia-Inducible Factor-1. Cell Growth Differ. 2001, 12, 363-369.
64. Zundel, W.; Schindler, C.; Haas-Kogan, D.; Koong, A.; Kaper, F.; Chen, E.; Gottschalk, A. R.; Ryan, H. E.; Johnson, R. S.; Jefferson, A. B.; Stokoe, D.; Giaccia, A. J. Loss of PTEN Facilitates HIF-1-Mediated Gene Expression. Genes Develop. 2000, 14, 391-396.
65. Hudson, C. C.; Liu, M.; Chiang, G. G.; Ottemess, D. M.; Loomis, D. C.; Kaper, F.; Giaccia, A. J.; Abraham, R. T. Regulation of Hypoxia-Inducible Fator 1 Alpha Expression and Function by the Mammalian Target of Rapamycin. Mol. Cell Biol. 2002, 22, 7004-7014.
66. Sosnowski, R.; Mellon, P. L.; Lawson, M. A. Activation of Translation in Pituitary Gonadotrope Cells by Gonadotropin-Releasing Hormone. Mol. Endocrinol. 2000, 14, 1811-1819.
67. Lang, K. J. D.; Kappel, A.; Goodall, G. J. Hypoxia-Inducible Inducible Factor-1α Mrna Contains an Internal Ribosome Entry Site that Allows Efficient Translation During Normoxia and Hypoxia. Mol. Biol. Cell 2002, 13, 1792-1801.
68. Alvarez-Tejado, M.; Naranjo-Suarez, S.; Jimenez, C.; Carrera, AC.; Landazuri, MO.; Del Peso, L. Hypoxia Induces the Activation of the Phosphatidylinositol 3-Kinase/AKT Cell Survival Pathway in PC12 Cells: Protective Role in Apoptosis. J. Biol. Chem. 2001, 276, 22368-22374.
69. Chilov, D.; Camneish, G.; Kvietikova, I.; Ziegler, U.; Gassmann, M.; Wenger, R. H. Induction and Nuclear Translocation of Hypoxia-Inducible Factor-1(HIF-1): Heterodimerization With ARNT is not Necessary For Nuclear Accumulation of HIF-1a. J. Cell Sci. 1999, 112, 1203-1212.
70. Kallio, PJ.; Okamoto, K.; O'Brian, S.; Carrero, P.; Makino, Y.; Tanaka, H.; Poellinger, L. Signal Transduction in Hypoxic Cells: Inducible Nuclear Translocation and Recruitment of the CBP/P300 Coactivator by the Hypoxia-Inducible Factor-1 Alpha. EMBO J. 1998, 17, 6573-6586.
71. Hofer, T.; Desbaillets, I.; Hopfl, G.; Gassmann, M.; Wenger, R. H. Dissecting Hypoxia-Dependent and Hypoxia-Independent Steps in Te HIF-1alpha Activation Cascade: Iplications for HIF-1alpha Gene Therapy. FASEB J. 2001, 15, 2715-2717.
72. Forsyth, J. A.; Jiang, B. H.; Iyer, N. V.; Agani, F.; Leung, SW.; Koos, R. D.; Semenza, GL. Activation of Vascular Endothelial Growth Factor Gene Transcription by Hypoxia-Inducible Factor 1. Mol. Cell Biol. 1996, 16, 4604-4613.
73. Jiang, BH, Agani, F.; Passaniti, A.; Semenza, GL. V-SRC Induces Expression of Hypoxia-Inducible Factor 1 (HIF-1) and Transcription of Genes Encoding Vascular Endothelial Growth Factor and Enolase 1: Involvement of HIF-I in Tumor Progression. Cancer Res. 1997, 57, 5328-5335.
74. Li, H.; Ko, H. P.; Whitlock, J. P. Induction of Phosphoglycerate Kinase 1 Gene Expression by Hypoxia. Roles of Arnt and HIF1alpha. J. Biol. Chem. 1996, 271, 21262-21267.
75. Pugh, C. W.; O'Rourke, J. F.; Nagao, M.; Gleadle, J.; Ratcliffe, P. J. Activation of Hypoxia-Inducible Factor-1; Definition of Regulatory Domains Within the Alpha Subunit. J. Biol. Chem. 1997, 272, 11205-11214.
76. 2 Homeostasis by Hypoxia-Inducible Factor 1. Annu. Rev. Cell Dev. Biol. 1999, 15, 551-578.
77. 2 Homeostasis. Curr. Opin. Genet. Dev. 1998, 8, 588-594.
78. Freedman, S. J.; Sun, Z. Y.; Poy, F.; Kung, A. L.; Livingston, D. M.; Wagner, G.; Eck, M. J. Structural Basis for Recruitment of CBP/P300 by Hypoxia-Inducible Factor-1 Alpha. Proc. Natl. Acad. Sci. U.S.A. 2002, 99, 5367-5372.
79. Dames, S. A.; Martinez-Yamout, M.; De Guzman, R. N.; Dyson, H. J.; Wright, P. E. Structural Basis for HIF-1 Alpha/CBP Recognition in the Cellular Hypoxic Response. Proc. Natl. Acad. Sci. U.S.A. 2002, 99, 5271-5276.
80. Sang, N.; Fang, J.; Srinivas, V.; Leshchinsky, I.; Caro, J. Carboxyl-Terminal Transactivation Activity of Hypoxia-Inducible Factor 1 Alpha is Governed by a Von Hippel-Lindau Protein-Independent, Hydroxylation-Regulated Association With P300/CBP. Mol. Cell. Biol. 2002, 22, 2984-2992.
81. Ruas, JL.; Poellinger, L.; Pereira, T. Functional Analysis of Hypoxia-Inducible Factor-1alpha-Mediated Transactivation. Identification of Amino Acid Residues Critical for Transcriptional Activation And/Or Interaction with Creb-Binding Protein. J. Biol. Chem. 2002, 277, 38723-38730.
82. Carrero, P.; Okamoto, K.; Coumailleau, P.; O'Brien, S.; Tanaka, H.; Poellinger, L. Redox-Regulated Recruitment of the Transcriptional Coactivators CREB-Binding Protein and SRC-I to Hypoxia-Inducible Factor 1α. Mol. Cell. Biol. 2000, 20, 402-415.
83. Bhattacharya, S.; Michels, C. L.; Leung, M. K.; Arany, Z. P.; Kung, A. L.; Livingston, D. J. Functional Role of p35srj, a Novel P300/CBP Binding Protein, During Transactivation by HIF-1. Genes Dev. 1999, 13, 64-75.
84. Lando, D.; Peet, D. J.; Whelan, D. A.; Gorman, J. J.; Whitlaw, M. L. Asparagine Hydroxylation of the HIF Transactivation Domain a Hypoxic Switch. Science 2002, 295, 858-861.
85. Mahon, P. C.; Hirota, K.; Semenza, G. L. FIH-1: a Novel Protein that Interacts with HIF-1a and VHL to Mediate Repression of HIF-1 Transcriptional Activity. Genes Develop. 2001, 15, 2675-2686.
86. Iliopoulos, O.; Levy, A. P.; Jiang, C.; Kaelin, W. G. Jr.; Goldberg, M. A. Negative Regulation of Hypoxia-Inducible Genes by the Von Hippel-Lindau Protein. Proc. Natl. Acad. Sci. U.S.A. 1996, 93, 10595-10599.
87. Maxwell, P. H.; Wiesener, M. S.; Chang, G.-W.; Clifford, S. C.; Vaux.; E. C.; Cockman.; M. E.; Wykof f, C. C.; Pugh, C. W.; Maher, E. R.; Ratcliffe, P. J. the Tumour Suppressor Protein VHL Targets Hypoxia-Inducible Factors for Oxygen-Dependent Proteolysis. Nature 1999, 399, 271-275.
88. Zeler, E.; Levy, Y.; Kahana, C.; Shilo, BS.; Rubinstein, M.; Cohen, B. Insulin Induces Transcription of Target Genes Through the Hypoxia-Inducible Factor HIF-1α/ARNT. EMBO J. 1998, 17, 5085-5094.
89. Agani, F. and Semenza, GL. Mersalyl is a Novel Inducer of Vascular Endothelial Growth Factor Gene Expression and Hypoxia-Inducible Factor 1 Activity. Mol. Pharmacol. 1998, 54, 749-754.
90. Feldser, D.; Agani, F.; Iyer, N. V.; Pak, B.; Ferreira, G.; Semenza, G. L. Reciprocal Positive Regulation of Hypoxia-Inducible Factor 1 Alpha and Insulin-Like Growth Factor 2. Cancer Res. 1999, 59, 3915-3918.
91. Hellwig-Burgel, T.; Rutkowski, K.; Metzen, E.; Fandrey, J.; Jelkmann, W. Interleukin-1β and Tumor Necrosis Factor-A Stimulate DNA Binding of Hypoxia-Inducible Factor-1. Blood 1999, 94, 1561-1567.
92. Thornton, RD.; Lane, P.; Bordghaei, RC.; Pease, EA.; Caro, J.; Mochan, E. Interleukin-1 Induces Hypoxia-Inducible Factor 1 in Human Gingival and Synovial Fibroblasts. Biochem. J. 2000, 350, 307-312.
93. Richard, D. E.; Berra, E.; Pouyssegur, J. Nonhypoxic Pathway Mediates the Induction of Hypoxia-Inducible Factor 1α in Vascular Smooth Muscle Cells. J. Biol. Chem. 2000, 275, 26765-26771.
94. Haddad, JJ. and Land, SC. a Non-Hypoxic ROS-Sensitive Pathway Mediates TNF-A-Dependent Regulation of HIF-1α. FEBS Lett. 2001, 505, 269-274.
95. phox -Containing NADPH Oxidase. Circ. Res. 2001, 89, 47-54.
96. Tacchini, L.; Dansi, P.; Matteucci, E.; Desiderio, M. A. Hepatocyte Growth Factor Signalling Stimulates Hypoxia Inducible Factor-1 (HIF-1) Activity in HepG2 Hepatoma Cells. Carcinogenesis 2001, 22, 1363-1371.
97. Stiehl, D. P.; Jelkmann, W.; Wenger, R. H.; Hellwig-Burgel, T. Normoxic Induction of the Hypoxia-Inducible Factor-1α by Insulin and Interleukin-1β Involves the Phosphatidylinositol 3-Kinase Pathway. FEBS Lett. 2002, 512, 157-162.
98. Wang, G. L.; Jiang, BH.; Semenza, GL. Effect of Protein Kinase and Phosphatase Inhibitors on Expression of Hypoxia-Inducible Factor 1. Biochem. Biophys. Res. Commun. 1995, 216, 669-675.
99. Richard, DE.; Berra, E.; Gothie, E.; Roux, D.; Pouyssegur, J. P42/P44 Mitogen-Activated Protein Kinases Phosphorylate Hypoxia-Inducible Factor 1α (HIF-1α) and Enhance the Transcriptional Activity of HIF-1. J. Biol. Chem. 1999, 274, 32631-32637.
100. Conrad, PW.; Freeman, TL.; Beitner-Johnson, D.; Millhorn, DE. EPAS1 Trans-Activation During Hypoxia Requires P42/P44 MAPK. J. Biol. Chem. 1999, 274, 33709-33713.
101. Berra, E.; Milanini, J.; Richard, D. E.; Le Gall, M.; Vinals, F.; Gothie, E.; Roux, D.; Pages, G.; Pouyssegur, J. Signaling Angiogenesis Via P42/P44 MAP Kinase and Hypoxia. Biochem. Pharmacol. 2000, 60, 1171-1178.
102. Sodhi, A.; Montaner, S.; Patel, V.; Zohar, M.; Bais, C.; Mesri, E. A.; Gutkind, J. S. The Kaposi's Sarcoma-Associated Herpes Virus G Protein-Coupled Receptor Up-Regulates Vascular Endothelial Growth Factor Expression and Secretion Through Mitogenactivated Protein Kinase and P38 Pathways Acting on Hypoxia-Inducible Factor 1α. Cancer Res. 2000, 60, 4873-4880.
103. Hur, E.; Chang, KY.; Lee, E.; Lee, SK.; Park, H. Mitogen-Activated Protein Kinase Kinase Inhibitor PD98059 Blocks the Trans-Activation But Not the Stabilization Or DNA Binding Ability of Hypoxia-Inducible Factor-1α. Mol. Pharmacol. 2001, 59, 1216-1224.
104. Grimshaw, M. J.; Balkwill, F. R. Inhibition of Monocyte and Macrophage Chemotaxis by Hypoxia and Inflammation-A Potential Mechanism. Eur. J. Immunol. 2001, 31, 480-489.
105. Zhong, H.; Chiles, K.; Feldser, D.; Laughner, E.; Hanrahan, C.; Georgescu, M. M.; Simons, J. W.; Semenza, G. L. Modulation of Hypoxia-Inducible Factor 1 Alpha Expression by the Epidermal Growth Factor/Phosphatidylinositol 3-Kinase/PTEN/AKT/FRAP Pathway in Human Prostate Cancer Cells: Implications for Tumor Angiogenesis and Therapeutics. Cancer Res. 2000, 60, 1541-1545.
106. Chen, E. Y.; Mazure, N. M.; Cooper, J. A.; Giaccia, A. J. Hypoxia Activates a Platelet-Derived Growth Factor Receptor/ Phosphatidylinositol 3-Kinase/Akt Pathway that Results in Glycogen Synthase Kinase-3 Inactivation. Cancer Res. 2001, 61, 2429-2433.
107. Jiang, B. H.; Zheng, J. Z.; Aoki, M.; Vogt, P. K. Phosphatidylinositol 3-Kinase Signaling Mediates Angiogenesis and Expression of Vascular Endothelial Growth Factor in Endothelial Cells. Proc. Natl. Acad. Sci. U.S.A. 2000, 97, 1749-1753.
108. Chen, C.; Pore, N.; Behrooz, A.; Ismail-Beigi, F.; Maity, A. Regulation of Glut1 mRNA by Hypoxia-Inducible Factor-1. Inteaction Between H-Ras and Hypoxia. J. Biol. Chem. 2001, 276, 9519-9525.
109. Ema, M.; Hirota, K.; Mimura, J.; Abe, H.; Yodoi, J.; Sogawa, K.; Poellinger, L.; Fujii-Kuriyama, Y. Molecular Mechanisms of Transcription Activation by HLF and HIF1alpha in Response to Hypoxia: Their Stabilization and Redox Signal-Induced Interaction With CBP/P300. EMBO J. 1999, 18, 1905-1914.
110. Wang, GL.; Jiang, BH.; Semenza, GL. Effect of Altered Redox Stqtes on Expression and DNA-Binding Activity of Hypoxia-Inducible Factor 1. Biochem. Biophys. Res. Commun. 1995, 212, 550-556.
111. Huang, L. E.; Arany, Z.; Livingston, D. M. Activation of Hypoxia Inducible Transcription Factor Depends Primarily Upon Redox-Sensitive Stabilization of Its Alpha Subunit. J. Biol. Chem. 1996, 271, 32253-32259.
112. Lando, D.; Pongratz, I.; Poellinger, L.; Whitelaw, ML. Redox-Regulated Recruitment of the Transcriptional Coactivators CREB-Binding Protein and SRC-1 to Hypoxia-Inducible Factor 1α. J. Biol. Chem. 2000, 275, 4618-4627.
113. 2 Evoked Regulation of HIF1α and NF-Kb Ion Perinatal Lung Epithelium Requires Glutathione Biosynthesis. Am. J. Physiol. 2003, 278, L492-L503.
114. Haddad, J. J.; OIver, R. E.; Land, S. C. Antioxidant/Pro-Oxidant Equilibrium Regulates HIF-1α and NF-Kb Redox Sensitivity. Evidence for Inhibition by Glutathione Oxidation in Alveolar Epithelial Cells. J. Biol. Chem. 2000, 275, 21130-21139.
115. Srinivas, V.; Zhu, X.; Salceda, S.; Nakamura, R.; Caro, J. Hypoxia-Inducible Factor 1alpha (HIF-1alpha) is a Non-Heme Iron Protein. Implications for Oxygen Sensing. J. Biol. Chem. 1998, 273, 18019-18022.
116. Welsh, SJ.; Bellamy, WT.; Briehl, MM.; Powis, G. the Redox Protein Thioredoxin-1 (Trx-1) Increases Hypoxia-Inducible Factor 1 alpha Protein Expression: Trx-1 Overexpression Results in Increased Vascular Endothelial Growth Factor Production and Enhanced Tumor Angiogenesis. Cancer Res. 2002, 62, 5089-5095.
117. Powis, G. and Montfort, WR. Properties and Biological Activities of Thioredoxins. Annu. Rev. Pharmacol. Toxicol. 2001, 41, 261-295.
118. Saitoh, M.; Nishitoh, H.; Fujii, M.; Takeda, K.; Tobiume, K.; Sawada, Y. ; Kawabata, M.; Miyazono, K.; Ichijo, H. Mammalian Thioredoxin is a Direct Inhibitor of Apoptosis Signal-Regulating Kinase (ASK) 1. EMBO J. 1998, 17, 2596-2606.
119. Hayashi, T.; Ueno, Y.; Okamoto, T. Oxidoreductive Regulation of Nuclear Factor Kappab: Involvement of a Cellular Reducing Catalyst Thioredoxin. J. Biol. Chem. 1993, 268, 11380-11388.
120. Makino, Y.; Yoshikawa, N.; Okamoto, K.; Hirota, K.; Yodoi, J.; Makino, I.; Tanaka, H. Direct Association With Thioredoxin Allows Redox Regulation of Glucocorticoid Receptor Function. J. Biol. Chem. 1999, 274, 3182-3188.
121. Ueno, M.; Masutani, H.; Jun Arai, R.; Yamauchi, A.; Hirota, K.; Sakai, T.; Inamoto, T.; Yamaoka, Y.; Yodoi, J.; Nikaido, T. Thioredoxin-Dependent Redox Regulation of P53-Mediated p21 Activation. J. Biol. Chem. 2000, 274, 35809-35815.
122. Huang, L. E.; Arany, Z.; Livingston, D. M. Activation of Hypoxia Inducible Transcription Factor Depends Primarily Upon Redox-Sensitive Stabilization of Its Alpha Subunit. J. Biol. Chem. 1996, 271, 32253-32259.
123. Flaherty, D. M.; Monic, M. M.; Hunninghake, G. W. AP Endonucleases and the Many Functions of Ref-1. Am. J. Respir. Cell Mol. Biol. 2001, 25, 6447-6449.
124. Hirota, K.; Matsui, M.; Iwata, S.; Nishiyama, A.; Mori, K.; Yodoi, J. AP-1 Transcriptional Activity is Regulated by a Direct Association Between Thioredoxin and Ref-1. Proc. Natl. Acad. Sci. U.S.A. 1997, 94, 3633-3638.
125. O'Rourke, J. F.; Tian, Y. M.; Ratcliffe, P. J.; Pugh, C. W. Oxygen-Regulated and Transactivating Domains in Endothelial PAS Protein 1: Comparison with Hypoxia-Inducible Factor-1alpha. J. Biol. Chem. 1999, 274, 2060-2071.
126. Giatromanolaki, A.; Koukourakis, M. L.; Sivridis, E.; Turley, H.; Talks, K. Relation of Hypoxia Inducible Factor 1 Alpha and 2 Alpha in Operable Non-Small Cell Lung Cancer to Angiogenicmolecular Profile of Tumors and Survival. Br. J. Cancer 2001, 85, 881-890.
127. Birner, P.; Schindl, M.; Obermair, A.; Breitenecker, G.; Oberhuber, G. Expression of Hypoxia-Inducible Factor-1 Alpha in Epithelial Ovarian Tumors: Its Impact on Prognosis and on Response to Chemotherapy. Clin. Cancer Res. 2001, 7, 1661-1668.
128. Aebersold, D. M.; Burri, P.; Beer, K. T.; Laissue, J.; Djonov, V.; Greiner, R. H.; Semenza, G. L. Expression of Hypoxia-Inducible Factor-1alpha: a Novel Predictive and Prognostic Parameter in the Radiotherapy of Oropharyngeal Cancer. Cancer Res. 2001, 61, 2911-2916.
129. Birner, P.; Schindl, M.; Obermair, A.; Plank, C.; Breitenecker, G.; Oberhuber, G. Over-Expression of Hypoxia-Inducible Factor-1alpha is a Marker for an Unfavorable Prognosis in Early-Stage Invasive Cervical Cancer. Cancer Res. 2000, 60, 4693-4696.,
130. Zhong, H.; De Marco, A. M.; Laughner, E.; Lim, M.; Hilton, D. A.; Zagzag, D.; Beuchler, P.; Isaacs, W. B.; Semenza, G. L.; Simons, J. W. Over-Expression of Hypoxia-Inducible Factor 1 Alpha in Common Human Cancers and Metastases. Cancer Res. 1999, 59, 5830-5835.
131. Zagzag, D.; Zhong, H.; Scalzetti, J. M.; Laughner, E.; Simons, J. W.; Semenza, G. L. Expression of Hypoxia-Inducible Factor-I Alpha in Brain Tumors: Association with Angiogenesis, Invasion and Progression. Cancer 2000, 88, 2606-2618.
132. Neufeld, G.; Kessler, O.; Vadasz, Z.; Gluzman-Poltorak, Z. the Contribution of Proangiogenic Factors to the Progression of Malignant Disease: Role of Vascular Endothelial Growth Factor and Its Receptors. Surg. Oncol. Cl. N. Amer. 2001, 10, 339-356.
133. Leung, S. Y.; Chan, A. S.; Wong, M. P.; Yuen, S. T.; Cheung, N.; Chung, L. P. Expression of Vascular Endothelial Growth Factor and Its Receptors in Pilocytic Astrocytoma. Am. J. Surg. Pathol. 1997, 21, 941-950.
134. Pietsch, T.; Valter, M. M.; Wolf, H. K.; Von Deimling, A.; Huang, H. J.; Cavenee, W. K.; Wiestler, O. D. Expression and Distribution of Vascular Endothelial Growth Factor Protein in Human Brain Tumors. Acta Neuropathol. 1997, 93, 109-117.
135. Takano, S.; Yoshii, Y.; Kondo, S.; Suzuki, H.; Maruno, T.; Shirai, S.; Nose, T. Concentration of Vascular Endothelial Growth Factor in the Serum and Tumor Tissue of Brain Tumor Patients. Cancer Res. 1996, 56, 2185-2190.
136. Takekawa, Y.; Sawada, T. Vascular Endothelial Growth Factor and Neovascularization in Astrocytic Tumors. Pathol. Int. 1998, 48, 109-114.
137. Ohh, M.; Park, C. W.; Ivan, M.; Hoffman, M. A.; Kim, T. Y.; Huang, L. E. ; Pavletich, N.; Chau, V.; Kaelin, W. G. Ubiquitination of Hypoxia-Inducible Factor Requires Direct Binding to the B-Domain of the Von Hippel-Lindau Protein. Nature Cell Biol. 2000, 2, 423-427.
138. Cockman, M. E.; Masson, N.; Mole, D. D. R.; Jaakkola, P.; Chang, G. W.; Clifford, S. C.; Maher, E. R.; Pugh, C. W.; Ratcliffe, P. J.; Maxwell, P. H. Hypoxia Inducible Factor-A Binding and Ubiquitylation by the Von Hippel-Lindau Tumor Suppressor Protein. J. Biol. Chem. 2000, 275, 25733-25741.
139. Tanimoto, K.; Makino, Y.; Pereira, T.; Poellinger, L. Mechanism of Regulation of the Hypodia-Inducible Factor-1α by the Von Hippel-Lindau Tumor Suppressor Protein. EMBO J. 2000, 19, 4298-4309.
140. Kamura, T.; Sato, S.; Iwai, K.; Czyzyk-Krzeska, M.; Conaway, R. C.; Conaway, J. W. Activation of HIF1α Ubiquitination by a Reconstituted Von Hippel-Lindau (VHL) Tumor Suppressor Complex. Proc. Natl. Acad. Sci. U.S.A. 2000, 97, 10430-10435.
141. Krieg, M.; Haas, R.; Brauch, H.; Acker, T.; Flamme, I.; Plate, KH. Up-Regulation of Hypoxia-Inducible Factors HIF-1α and HIF-2α Under Normoxic Conditions in Renal Carcinoma Cells by Von Hippel-Lindau Tumor Suppressor Gene Loss of Function. Oncogene 2000, 19, 5435-5443.
142. Clifford, S. C.; Cockma, M. D.; Smallwood, A. C.; Mole, D. R.; Woodward, E. R.; Maxwell, P. H.; Ratcliffe, P. J.; Maher, E. R. Contrasting Effect on HIF-1α Regulation by Disease-Causing Pvhl Mutations Correlate with Patterns of Tumourigenesis in Von Hippel-Lindau Disease. Hum. Mol. Genet. 2001, 10, 1029-1038.
143. Vaux, E. C.; Wood, S. M.; Cockman, M. E.; Nicholls, L. G.; Yeates, K. M. ; Pugh, C. W.; Maxwell, P. H.; Ratcliffe, P. J. Selection of Mutant CHO Cells with Constitutive Activation of the HIF System and Inactivation of the Von Hippel-Lindau Tumor Suppressor. J. Biol. Chem. 2001, 276, 44323-44330.
144. Yu, F.; White, S. B.; Zhao, Q.; Lee, F. S. Dynamic Site-Specific Interaction of Hypoxia-Inducible Factor-1α with the Von Hippel-Lindau Tumor Suppressor Protein. Cancer Res. 2001, 61, 4136-4142.
145. Wiesner, M. S.; Munchenhagen, P. M.; Berger, I.; Morgan, N. V.; Roigas, J.; Schwiertz, A.; Jurgensen, J. S.; Gruber, G.; Maxwell, P. H.; Loning, S. A.; Frei, U.; Maher, E. R.; Grone, H. J.; Eckardt, K. U. Constitutive Activation of Hypoxia-Inducible Genes Related to Overexpression of Hypoxia-Inducible Factor-1α in Clear Cell Renal Carcinomasl. Cancer Res. 2001, 61, 5215-5222.
146. Li, J.; Yen, C.; Liaw, D.; Podsypanina, K.; Bose, S.; Wang, S. I.; Puc, J.; Miliaresis, C.; Rodgers, L.; Mccombie, R.; Bigner, S. H.; Giovanella, B. C. ; Ittmann, M.; Tycko, B.; Hibshoosh, H.; Wigler, M. H.; Parsons, R. PTEN, a Putative Protein Tyrdosine Phosphatase Gene Mutated in Human Brain, Breast, and Prostate Cancer. Science 1997, 275, 1876-1878.
147. Mcmenamin, M. E.; Soung, P.; Perera, S.; Kaplan, I.; Loda, M.; Sellers, W. R. Loss of PTEN Expression in Paraffin-Embedded Primary Prosate Cancer Correlates with High Gleason Score and Advanced Stage. Cancer Res. 1999, 59, 4291-4296.
148. Giri, D.; Ittmann, M. Inactivation of the PTEN Tumor Suppressor Gene is Associated with Increased Angiogenesis in Clinically Localized Prostate Carcinoma. Hum. Pathol. 1999, 30, 419-424.
149. Volm, M.; Koomagi, R. Hypoxia-Inducible Factor (HIF-1) and Its Relationship to Apoptosis and Proliferation in Lung Cancer. Anti-Cancer Res. 2000, 20, 1527-1533.
150. Bruick, R. K. Expression of the Gene Encoding the Proapoptotic NIP3 Protein is Induced by Hypoxia. Proc. Natl. Acad. Sci. U.S.A. 2000, 97, 9082-9087.
151. Koukourakis, M. I.; Giatromanolaki, A.; Skarlatos, J.; Corti, L.; Blandamura, S.; Piazza, M.; Gatter, K. C.; Harris, A. L. Hypoxia Inducible Factor (HIF-1a and HIF-2a) Expression in Early Esophageal Cancer and Response to Photodynamic Therapy and Radiotherapy. Cancer Res. 2001, 61, 1830-1832.
152. Sun, X.; Kanwar, J. R.; Leung, E.; Lehnert, K.; Wang, D.; Krissansen, G. W. Gene Transfer of Antisense Hypoxia Inducible Factor-1 Alpha Enhances the Therapeutic Efficacy of Cancer Immunotherapy. Gene Ther. 2001, 8, 638-645.
153. Mabjeesh, N. J.; Escuin, D.; Lavallee, T. M.; Pribluda, V. S.; Swartz, G. M.; Johnson, M. S.; Willard, M. T.; Zhong, H.; Simons, J. W.; Giannakakou, P. 2ME2 Inhibits Tumor Growth and Angiogenesis by Disrupting Microtubules and Dysregulating HIF. Cancer Cell 2003, 3, 363-375.
154. Klauber, N.; Parangi, S.; Flynn, E.; Hamel, E.; D'Amato, R. J. Inhibition of Angiogenesis and Brest Cancer in Mice by the Microtubule Inhibitors 2-Methoxyestradiol and Taxol. Cancer Res. 1997, 57, 81-86.
155. Avramis, I. A.; Kwock, R.; Avramis, V. I. Taxotere and Vincristine Inhibit the Secretion of the Angiogenesis Inducing Vascular Endothelial Growth Factor (VEGF) by Wild-Type and Drug-Resistant Human Leukemia T-Cell Lines. Anti-Cancer Res. 2001, 21, 2281-2286.
156. Rapisarda, A.; Uranchimeg, B.; Scudiero, D. A.; Selby, M.; Sausville, E. A.; Shoemaker, R. H.; Melillo, G. Identification of Small Molecule Inhibitors of Hypoxia-Indiucible Factor 1 Transcriptional Activation Pathway. Cancer Res. 2002, 62, 4316-4324.
157. Laughner, E.; Taghavi, P.; Chiles, K.; Mahon, P. C.; Semenza, G. L. HER2(Neu) Signaling Increases the Rate of Hypoxia-Inducible Factor 1a(HIF-1a) Synthesis: Novel Mechanism for HIF-1-Mediated Vascular Endothelial Growth Factor Expression. Mol. Cell. Biol. 2001, 21, 3995-4004.
158. Maloney, A.; Workman, P. HSP90 as a New Therapeutic Target for Cancer Therapy: the Story Unfolds. Expert Opin. Biol. Ther. 2002, 2, 3-24.
159. Coumailleau, P.; Poellinger, L.; Gustafsson, J. A.; Whitelaw, ML. Definition of a Minimal Domain of the Dioxin Receptor that is Associated with Hsp90 and Maintains Wild Type Ligand Binding Affinity and Specificity. J. Biol. Chem. 1995, 270, 25291-25300.
160. Sanchez, E. R.; Toft, D. O.; Schlesinger, M. J.; Pratt, W. B. Evidence that the 90-kDa Phosphoprotein Associated with the Untransformed L-Cell Glucocorticoid Receptor is a Murine Heat Shock Protein. J. Biol. Chem. 1985, 260, 12398-12401.
161. Shaknovich, R.; Shue, G.; Kohtz, D. S. Conformational Activaton of a Basic Helix-Loop-Helix Protein (Myod1) by the C-Terminal Region of Murine HSP90 (HSP84). Mol. Cell Biol. 1992, 12, 5059-5068.
162. Blagosklonny, M. V.; Toretsky, J.; Bohen, S.; Neckers, L. Mutant Conformation of p53 Translated in Vitro or in Vivo Requires Functional HSP90. Proc. Natl. Acad. Sci. U.S.A. 1996, 93, 8379-8383.
163. Sato, S.; Fujita, N.; Tsuruo, T. Modulation of Akt Kinase Activity by Binding to Hsp90. Proc. Natl. Acad. Sci, U.S.A. 2000, 97, 10832-10837.
164. Xu, W.; Mimnaugh, E.; Rossser, M. F.; Nicchitta, C.; Marcu, M.; Yarden, Y.; Neckers, L. Sensitivity of Mature Erbb2 to Geldanamycin is Conferred by Its Kinase Domain and is Mediated by the Chaperone Protein Hsp90. J. Biol. Chem. 2001, 276, 3702-3708.
165. Stancato, L. F.; Chow, Y. H.; Hutchison, K. A.; Perdew, G. H.; Jove, R.; Pratt, W. B. Raf Exists in a Native Heterocomplex with Hsp90 and P50 that Can Be Reconstituted in a Cell-Free System. J. Biol. Chem. 1993, 268, 21711-21716.
166. Brugge, J. S.; Erikson, E.; Erikson, R. L. the Specific Interaction of the Rous Sarcoma Virus Transforming Protein Pp60src, with Two Cellular Proteins. Cell 1981, 25, 363-372.
167. Mimnaugh, E. G.; Chavany, C.; Neckers, L. Polyubiquitination and Proteasomal Degradation of the P185c-Erbb-2 Receptor Protein-Tyrosine Kinase Induced by Geldanamycin. J. Biol. Chem. 1996, 271, 22796-22801.
168. Schulte, T. W.; An, W. G.; Neckers, L. M. Geldanamycin-Induced Destabilization of Raf-1 Involves the Proteasome. Biochem. Biophys. Res. Commun. 1997, 239, 655-659.
169. Whitesell, L.; Sutphin, P.; An, W. G.; Schulte, T.; Blagosklonny, M. V.; Neckers, L. Geldanamycin-Stimulated Destabilization of Mutated P53 is Mediated by the Proteasome in vivo. Oncogene 1997, 14, 2809-2816.
170. Nguyen, D. M.; Desai, S.; Chen, A.; Weiser, T. A.; Schrump, D. S. Modulation of Metastasis Phenotypes of Non-Small Cell Lung Cancer Cells by 17-Allylamino 17-Demethoxy Geldanamycin. Ann. Thorac. Surg. 2000, 70, 1853-1860.
171. Kurebayashi, J.; Otsuki, T.; Kurosumi, M.; Soga, S.; Akinaga, S.; Sonoo, H. A Radicicol Derivative KF58333, Inhibits Expression of Hypoxia-Inducible Factor-1alpha and Vascular Endothelial Growth Factor, Angiogenesis and Growth of Human Breast Cancer Xenografts. Jpn. J. Cancer Res. 2001, 92, 1342-1351.
172. Chun, Y. S.; Yeo, E. J.; Choi, E.; Teng, C. M.; Bai, J. M.; Kim, M. S.; Park, J. W. Inhibitory Effect of YC-1 on the Hypoxic Induction of Erythropoietin and Vascular Endothelial Growth Factor in Hep3B Cells. Biochem. Pharmacol. 2000, 61, 947-954.
173. Huang, L. E.; Willmore, W. G.; Gu, J.; Goldberg, M. A.; Bunn, H. F. Inhibition of Hypoxia-Inducible Factor 1 Activation by Carbon Monoxide and Nitric Oxide. Implications for Oxygen Sensing and Signaling. J. Biol. Chem. 1999, 274, 9038-9044.
174. Wang, F.; Sekine, H.; Kikuchi, Y.; Takasaki, C.; Miura, C.; Heiwa, O.; Shuin, T.; Fujii-Kuriyama, Y.; Sogawa, K. HIF-1alpha-Prolyl Hydroxylase: Molecular Target of Nitric Oxide in the Hypoxic Signal Transduction Pathway. Biochem. Biophys. Res. Commun. 2002, 295, 657-662.
175. Yeo, E. J.; Chun, Y. S.; Cho, Y. S.; Kim, J.; Lee, J. C.; Kim, M. S.; Park, J. W. YC-1: a Potential Anticancer Drug Targeting Hypoxia-Inducible Factor1. J. Natl. Cancer Inst. 2003, 95, 516-525.
176. Welsh, S. J.; Williams, R. R.; Birmingham, A.; Newman, D. J.; Kirkpatrick, D. L.; Powis, G. The Thioredoxin Redox Inhibitors 1-Methylpropyl 2-Imidazolyl Disulfide and Pleurotin Inhibit Hypoxia-Induced Factor 1α and Vascular Endothelial Growth Factor formation. Mol. Cancer Therap. 2003, 2, 235-243.
177. Welsh, S. J.; Williams, R.; Berggren, M.; Kirkpatrick, D. L.; Powis, G. the Antitumor Activity of PX-478 an Inhibitor of Hypokia-Induvible Factor-1a(HIF-1α) is Associated Wit Decreased Tumor HIF-1α and Plasma VEGF. Proc Am Assoc Cancer Res. 2003, 44, 4634-4634.
178. Albina, J. E.; Mastrofrancesco, B.; Vessella, J. A.; Louis, C. A.; Henry, W. L. Jr.; Reichner, J. S. HIF-1 Expression in Healing Wounds: HIF-1 Alpha Induction in Primary Inflammatory Cells by TNF-Alpha. Am. J. Physiol. 2001, 281, X1971-X1977.
179. Blancher, C.; Moore, J. W.; Talks, K. L.; Houlbrook, S.; Harris, A L. Relationship of Hypoxia-Inducible Factor (HIF)-1alpha and HIF-2alpha Expression to Vascular Endothelial Growth Factor Induction and Hypoxia Survival in Human Breast Cancer Cell Lines. Cancer Res. 2000, 60, 7106-7113.
180. Yu, J. L.; Rak, J. W.; Carmeliet, P.; Nagy, A.; Kerbel, R. S.; Coomber, B. L. Heterogeneous Vascular Dependence of Tumor Cell Populations. Am. J. Pathol. 2001, 158, 1325-1334.
181. Cory, S.; Adams, J. M. the Bcl2 Family: Regulators of the Cellular Life-or-Death Switch. Nature Rev. Cancer 2002, 2, 647-656.
182. Holcik, M.; Sonenberg, N.; Korneluk, R. G. Internal Ribosome Initiation of Translation and the Control of Cell Death. Transl. Cell Death 2000, 16, 469-473.
183. Kraggerud, S. M.; Sandvik, J. A.; Pettersen, E. O. Regulation of Protein Synthesis in Human Cells Exposed to Extreme Hypoxia. Anti-Cancer Res. 1995, 15, 683-686.
184. Akiri, G.; Nahari, D.; Finkelstein, Y.; Le, S. Y.; Elroystein, O.; Levi, B. Z. Regulation of Vascular Endothelial Growth Factor (VEGF) Expression is Mediated by Internal Initiation of Translation and Alternative Initiation of Transcription. Oncogene 1998, 17, 227-236.
185. Creancier, L.; Morello, D.; Mercier, P.; Prats, A. C. Fibroblast Gdrowth Factor 2 Internal Ribosome Entry Site (IRES) Activity Ex Vivo and in Transgenic Mice Reveals a Stringent Tissue-Specific Regulation. J. Cell Biol. 2000, 150, 275-281.
186. Gerlitz, G.; Jagus, R.; Elroy-Stein, O. Phosphorylation of Initiation Factor-2 Alpha is Required for Activation of Internal Translation Initiation During Cell Differentiation. Eur. J. Biochem. 2002, 269, 2810-2819.
187. Koumenis, C.; Naczki, C.; Koritzinsky, M.; Rastani, S.; Diehl, A.; Sonenberg, N.; Koromilas, A.; Wouters, B. G. Regulation of Protein Synthesis by Hypoxia Via Activation of the Endoplasmic Reticulum Kinase PERK and Phosphorylation of the Translation Initiation Factor Eif2α. Mol. Cell Biol. 2002, 22, 7405-7416.
188. Wouters, B. G.; Weppler, S. A.; Koritzinsky, M.; Landuyt, W.; Nuyts, S.; Theys, J.; Chiu, R. K.; Lambin, P. Hypoxia as a Target for Combined Modality Treatments. Eur. J. Cancer 2002, 38, 240-257.
189. Wood, S. M.; Wiesener, M. S.; Yeates, K. M.; Okada, N.; Pugh, C. W.; Maxwell, P. H.; Ratcliffe, P. J. Selection and Analysis of a Mutant Cell Line Defective in the Hypoxia-Inducible Factor-1 Alpha-Subunit (HIF-1alpha). Characterization of Hif-1alpha-Dependent and -Independent Hypoxia-Inducible Gene Expression. J. Biol. Chem. 1998, 273, 8360-8368.
190. Eckhart, A. D.; Yang, N.; Xin, X.; Faber, J. E. Characterization of the Alpha1b-Adrenergic Receptor Gene Promoter Region and Hypoxia Regulatory Elements in Vascular Smooth Muscle. Proc. Natl. Acad Sci. U.S.A. 1997, 94,9487-9492.
191. Cormier-Regard, S.; Nguyen, S. V.; Claycomb, W. C. Adrenomedullin Gene Expression is Developmentally Regulated and Induced by Hypoxia in Rat Ventricular Cardiac Myocytes. J. Biol. Chem. 1998, 273, 17787-17792.
192. Wykoff, C. C.; Beasley, N. J.; Watson, P. H.; Turner, K. J.; Pastorek, J.; Sibtain, A.; Wilson, G. D.; Turley, H.; Talks, K. L.; Maxwell, P. H.; Pugh, C. W.; Ratcliffe, P. J.; Harris, A. L. Hypoxia-Inducible Expression of Tumor-Associated Carbonic Anhydrases. Cancer Res. 2000, 60, 7075-7083.
193. Mukhopadhyay, C. K.; Mazumder, B.; Fox, P. L. Role of Hypoxia-Inducible Factor-1 in Transcriptional Activation of Ceruloplasmin by Iron Deficiency. J. Biol. Chem. 2000, 275, 21048-21054.
194. Kietzmann, T.; Roth, U.; Jungermann, K. Induction of the Plasminogen Activator Inhibitor-1 Gene Expression by Mild Hypoxia Via a Hypoxia Response Element Binding the Hypoxia-Inducible Factor-1 in Rat Hepatocytes. Blood 1999, 94, 4177-4185.
195. Hu, J.; Discher, D. J.; Bishopric, N. H.; Webster, K. A. Hypoxia Regulates Expression of the Endothelin-1 Gene through a Proximal Hypoxia-Inducible Factor-1 Binding Site on the Antisense Strand. Biochem. Biophys. Res. Commun. 1998, 245, 894-899.
196. Oikawa, M.; Abe, M.; Kurosawa, H.; Hida, W.; Shirato, K.; Sato, Y. Hypoxia Induces Transcription Factor ETS-1 via the Activity of Hypoxia-Inducible Factor-1. Biochem. Biophys. Res. Commun. 2001, 289, 39-43.
197. Hogenesch, J. B.; Gu, Y. Z.; Moran, S. M.; Shimomura, K., Radcliffe, L. A.; Takahashi, J. S.; Bradfield, C. A. The Basic Helix-Loop-Helix-PAS Protein MOP9 is a Brain-Specific Heterodimeric Partner of Circadian and Hypoxia Factors. J. Neurosci. 2000, 20, RC83(1-5).
198. Lee, P. J.; Jiang, B. H.; Chin, B. Y.; Iyer, N. V.; Alam, J.; Semenza, G. L.; Choi, A. M. Hypoxia-Inducible Factor-1 Mediates Transcriptional Activation of the Heme Oxygenase-1 Gene in Response to Hypoxia. J. Biol. Chem. 1997, 272, 5375-5381.
199. Tazuke, S. I.; Mazure, N. M.; Sugawara, J.; Carland, G.; Faessen, G. H.; Suen, L. F.; Irwin, J. C.; Powell, D. R.; Giaccia, A. J.; Giudice, L. C. Hypoxia Stimulates Insulliln-Like Growth Factor Binding Protein 1 (IGFBP-1) Gene Expression in HepG2 Cells: a Possible Model for IGFBP-1 Expression in Fetal Hypoxia. Proc. Natl. Acad. Sci. U.S.A. 1998, 95, 10188-10193.
200. Furuta, G. T.; Turner, J. R.; Taylor, C. T.; Hershberg, R. M.; Comerford, K.; Narravula, S.; Podolsky, D. K.; Colgan, S. P. Hypoxia-Inducible Factor 1-Dependent Induction of Intestinal Trefoil Factor Protects Barrier Function During Hypoxia. J. Exp. Med. 2001, 193, 1027-1034.
201. Palmer, L. A.; Johns, R. A. Hypoxia Upregulates Inducible (Type II) Nitric Oxide Synthase in an HIF-1 Dependent Manner in Rat Pulmonary Microvascular But Not Aortic Smooth Muscle Cells. Chest 1998, 114, 33S-34S.
202. Takahashi, Y.; Takahashi, S.; Shiga, Y.; Yoshimi, T.; Miura, T. Hypoxic Induction of Prolyl 4-Hydroxylase Alpha (1) in Cultured Cells. J. Biol. Chem. 2000, 275, 14139-14146.
203. Estes, S. D.; Stoler, D. L.; Anderson, G. R. Anoxic Induction of a Sarcoma Virus-Related VL30 Retrotransposon is Mediated by a Cis-Acting Element Which Binds Hypoxia-Inducible Factor 1 and an Anoxia-Inducible Factor. J. Virol. 1995, 69, 6335-6341.
204. Rolfs, A.; Kvietikova, I.; Gassmann, M.; Wenger, R. H. Oxygen-Regulated Transferrin Expression is Mediated by Hypoxia-Inducible Factor-1. J. Biol. Chem. 1997, 272, 20055-20062.
205. Lok, C. N.; Ponka, P. Identification of a Hypoxia Response Element in the Transferrin Receptor Gene. J. Biol. Chem. 1999, 274, 24147-24152.
206. Tacchini, L.; Bianchi, L.; Bernelli-Zazzera, A.; Cairo, G. Transferrin Receptor Induction by Hypoxia. HIF-1-Mediated Transcriptional Activation and Cell-Specific Post-Transcriptional Regulation. J. Biol. Chem. 1999, 274, 24142-24146.
207. Caniggia, I.; Mostachfi, H.; Winter, J.; Gassmann, M.; Lye, SJ.; Kuliszewski, M.; Post, M. Hypoxia-Inducible Factor-1 Mediates the Biological Effects of Oxygen on Human Trophoblast Differentiation Through Tgfbeta(3). J. Clin. Invest. 2000, 105, 577-587.
208. Gerber, H. P.; Condorelli, F.; Park, J.; Ferrara, N. Differential Transcriptional Regulation of the Two Vascular Endothelial Growth Factor Receptor Genes. Flt-1, But Not Flk-1/KDR, is Up-Regulated by Hypoxia. J. Biol. Chem. 1997, 272, 23656-23667.
209. Minchenko, A.; Salceda, S.; Bauer, T. Hypoxia Regulatory Elements of the Human Vascular Endothelial Growth Factor Gene. Cell Mol. Biol. Res. 1994, 40, 35-39.
210. Blancher, C.; Moore, J. W.; Robertson, N.; Harris, A. L. Effects of Ras and Von Hippel-Lindau (VHL) Gene Mutations on Hypoxia-Inducible Factor (HIF)-1alpha, HIF-2alpha, and Vascular Endothelial Growth Factor Expression and Their Regulation by the Phosphatidylinositol 3′-Kinase/Akt Signaling Pathway. Cancer Res. 2001, 61, 7349-7355.
211. Gleadle, J. M.; Ebert, B. L.; Ratcliffe, P. J. Diphenylene Iodonium Inhibits the Induction of Erythrdopoietin and Other Mammalian Genes by Hypoxia. Implications for the Mechanism of Oxygen Sensing. Eur. J. Biochem. 1995, 234, 92-99.